LIFE Stock Ethos Technologies (LIFE, $27.65) was a top quarterly gainer, rising +19.59%
at Tickeron.com
Loading...
Ethos Technologies (LIFE, $27.65) was one of top quarterly gainers, jumping +1 to $27.65 per share. A.I.dvisor analyzed 20 stocks in the Insurance Brokers/Services Industry over the last three months, and discovered that of them (9) charted an Uptrend while of them () trended down.
Aroon Indicator for LIFE shows an upward move is likely
LIFE's Aroon Indicator triggered a bullish signal on July 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 81 similar instances where the Aroon Indicator showed a similar pattern. In of the 81 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 29, 2026. You may want to consider a long position or call options on LIFE as a result. In of 52 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for LIFE just turned positive on July 29, 2026. Looking at past instances where LIFE's MACD turned positive, the stock continued to rise in of 23 cases over the following month. The odds of a continued upward trend are .
LIFE moved above its 50-day moving average on July 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LIFE crossed bullishly above the 50-day moving average on July 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LIFE advanced for three days, in of 160 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
LIFE broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LIFE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.488) is normal, around the industry mean (8.189). P/E Ratio (22.539) is within average values for comparable stocks, (37.087). LIFE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.736). LIFE's Dividend Yield (0.000) is considerably lower than the industry average of (0.013). P/S Ratio (3.643) is also within normal values, averaging (3.385).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.